Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
J. Randolph Hecht, Young Suk Park, Josep Tabernero, Myung Ah Lee et autres
30 citationsThe Lancet
A.C. Virgili Manrique
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
50Publications signalées
410Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Colorectal Cancer Treatments and StudiesChronic Myeloid Leukemia TreatmentsCancer Genomics and DiagnosticsColorectal Cancer Surgical TreatmentsCancer Immunotherapy and Biomarkers
Publications récentes
Nanotoxin induces in situ pyroptosis to sensitize αPD1 to ablate metastases in microsattellite stable colorectal cancer
Luis Miguel Carrasco-Díaz, Marc Otero-Mateo, Patricia Álamo, Alberto Gallardo et autres
0 citationsPharmacological Research
789P Characterization of locally advanced rectal cancer (LARC) patients (pt) in Spanish TTD-RETUD registry
M.A. Gomez España, S. Gil Calle, Encarnación González‐Flores, M. Melián Sosa et autres
0 citationsAnnals of Oncology
771P Clinicopathological and molecular features of recurrence in ctDNA-negative resected colorectal cancer
J. Sanz Beltran, Raphael Ferreira Perez, A.C. Virgili Manrique, B. Martin Cullell et autres
0 citationsAnnals of Oncology
LBA30 Zanzalintinib plus atezolizumab (zanza + atezo) vs regorafenib (rego) in patients (pts) with previously treated metastatic colorectal cancer (mCRC): Primary overall survival (OS) analysis from the randomized, open-label, phase III STELLAR-303 study
Anwaar Saeed, Y. S. Park, J. Tabernero, M.A. Lee et autres
0 citationsAnnals of Oncology
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Alessandro Audisio, Chiara Gallio, Vaneja Velenik, Hélène Meillat et autres
24 citationsJAMA Oncology
34P Relevance of ABCG2 and SRPK1 genetic variants in irinotecan-induced severe toxicity
Iván Martín da Silva, Pau Riera, Sara Bernal, A.C. Virgili Manrique et autres
0 citationsAnnals of Oncology
273P A retrospective single-center analysis of treatment strategies and real-world outcomes in locally advanced pancreatic cancer
J. Sanz Beltran, P. Cerdà Serdà, A. Romano Cardozo, M.A. Molina Pérez et autres
0 citationsAnnals of Oncology
Monitoring of adverse effects and quality of life during chemotherapy treatment through the EMMA Salud mobile App in patients with colorectal cancer
Pau Riera, Berta Martín-Cullell, A.C. Virgili Manrique, Lucía Barrientos-Ramírez et autres
0 citationsMedicina Clínica (English Edition)
Predictive factors of efficacy for FTD/TPI plus bevacizumab in refractory metastatic colorectal cancer patients: a subanalysis of the Spanish cohort from the SUNLIGHT phase III trial
Gemma Soler-González, Cristina Grávalos, Fernando Rivera, María José Safont et autres
0 citationsClinical & Translational Oncology
A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation
Luis Miguel Carrasco-Díaz, Alberto Gallardo, Eric Voltà‐Durán, A.C. Virgili Manrique et autres
10 citationsInternational Journal of Nanomedicine
Monitorización de efectos adversos y calidad de vida durante el tratamiento quimioterápico a través de la App móvil EMMA Salud en pacientes con cáncer colorrectal
Pau Riera, Berta Martín-Cullell, A.C. Virgili Manrique, Lucía Barrientos-Ramírez et autres
0 citationsMedicina Clínica
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.